Novartis Will Not Bid For Berna Biotech
Filed in archive Corporate and Industrial News on January 10, 2006
After much speculations, Novartis finally decides not to bid for Berna Biotech AG, leaving it up for Dutch biotechnology start-up firm, Crucell, to take-over.
"After completion of due diligence and an assessment of the potential benefits and risks of an acquisition, Novartis has decided not to make an offer for Berna Biotech," Novartis said on Tuesday in a statement.
Crucell shareholders are expected to vote on the company's plan to take over Berna for around $450 million at a meeting later on Tuesday.
Read the rest of the story from MSN Money.
Crucell shareholders are expected to vote on the company's plan to take over Berna for around $450 million at a meeting later on Tuesday.
Permalink: Novartis Will Not Bid For Berna Biotech
Tags: biotech shares berna novartis news berna+biotech stem+cells corporate+industrial
Vote for Novartis Will Not Bid For Berna Biotech:
|
Rating: 7.00 out of 2 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells